Home » Healthcare » Pharmaceuticals » India Laxatives Market

India Laxatives Market By Drug Type (Hyperosmotic Laxatives, Bulk-Forming Laxatives, Stool Softeners, Lubricants, Others); By Indication (Chronic Constipation, Irritable Bowel Syndrome (IBS), Others); By End User (Hospitals & Clinics, Research Institutes, Others); By Route of Administration (Oral, Rectal); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
India laxatives Market Size 2023	USD 373.83 million
India laxatives Market, CAGR	6.81%
India laxatives Market Size 2032	USD 682.72 million

Market Overview

The India laxatives market is projected to grow from USD 373.83 million in 2023 to an estimated USD 682.72 million by 2032, with a compound annual growth rate (CAGR) of 6.81% from 2024 to 2032. This growth is driven by increasing awareness of gastrointestinal health, a rising geriatric population, and the growing prevalence of lifestyle-related disorders that contribute to constipation and other digestive issues.

Market drivers include the increasing incidence of digestive disorders, heightened consumer awareness regarding digestive health, and the introduction of new and more effective laxative formulations. Additionally, the growing focus on natural and herbal laxatives, perceived as safer alternatives, is shaping market trends. The rise in healthcare expenditure and the expansion of the pharmaceutical sector further bolster market growth, particularly in urban regions where access to healthcare is more robust.

Geographically, the market is concentrated in urban areas, with significant demand from metropolitan cities such as Mumbai, Delhi, and Bangalore, where lifestyle disorders are more prevalent. The northern and western regions of India dominate the market share due to higher healthcare infrastructure and consumer spending. Key players in the India laxatives market include Abbott Laboratories, GlaxoSmithKline Plc, Cipla Ltd., Sanofi S.A., and Bayer AG, all of whom are focusing on expanding their product portfolios and increasing market penetration through strategic partnerships and marketing initiatives.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The growing prevalence of gastrointestinal disorders, including constipation, irritable bowel syndrome (IBS), and other digestive issues, is a significant driver for the laxatives market in India. For instance, a substantial portion of the adult population reported experiencing constipation regularly. The study also revealed that urbanization and changing dietary habits were key factors contributing to this trend. Additionally, a rise in lifestyle-related health issues, many of which are associated with digestive problems. The sedentary lifestyles and low-fiber diets were becoming increasingly common in urban areas. Furthermore, research by the Geriatric Society of India showed that a significant percentage of the elderly population suffers from chronic constipation, necessitating regular use of laxatives. These findings are corroborated by reports from the Indian Society of Gastroenterology, which noted an uptick in consultations related to digestive health issues across various age groups.

Growing Consumer Awareness and Self-Medication Trends

There has been a significant rise in consumer awareness regarding digestive health in India. For instance, awareness about the importance of digestive health has increased substantially over the past decade. The study noted that more people are now actively seeking information about digestive issues and their remedies. This trend which reported a rise in health literacy programs focusing on digestive health. Additionally, a growing number of urban consumers prefer self-medication for minor digestive issues. The study highlighted that convenience and cost-effectiveness were key factors driving this trend. Furthermore, research by the Pharmacy Council of India indicated a significant increase in over-the-counter sales of digestive health products, including laxatives. This trend is particularly pronounced in tier-1 and tier-2 cities, where access to information and products is more readily available.

Innovation and Product Diversification

The India laxatives market is benefiting from continuous innovation and product diversification by key players, who are introducing new formulations and delivery methods to cater to diverse consumer preferences. Traditionally, laxatives have been available in forms such as tablets, powders, and syrups. However, recent years have seen the introduction of more convenient and consumer-friendly formats, including capsules, soft gels, gummies, and even fiber-enriched snacks. These new formats are designed to improve the consumer experience by offering ease of use, faster onset of action, and better taste, which are important factors in encouraging regular use among consumers. Additionally, there is a growing trend towards natural and herbal laxatives, which are perceived as safer and less likely to cause side effects compared to synthetic alternatives. Companies are increasingly focusing on incorporating ingredients like psyllium husk, senna, and aloe vera into their products to appeal to health-conscious consumers. The emphasis on natural formulations is also in line with the broader trend of clean-label and plant-based products, which are gaining popularity across various sectors of the Indian market. This product diversification not only meets the evolving demands of consumers but also helps companies differentiate their offerings in a competitive market.

Expanding Healthcare Infrastructure and Rising Healthcare Expenditure

The expansion of healthcare infrastructure and rising healthcare expenditure in India are key drivers of the laxatives market. Over the past decade, the Indian government has made significant investments in improving healthcare facilities, particularly in rural and semi-urban areas. This has led to better access to healthcare services and medications, including laxatives, for a larger portion of the population. Additionally, the increasing penetration of private healthcare providers, coupled with the rise in health insurance coverage, has made it easier for consumers to afford medications and seek treatment for digestive issues. The growth of the pharmaceutical sector in India, which is one of the largest in the world, has also contributed to the availability of a wide range of laxative products at competitive prices. Moreover, as disposable incomes continue to rise, more consumers are willing to spend on health and wellness products, including laxatives. The shift towards preventive healthcare, where consumers proactively manage their health to avoid future medical expenses, is also driving demand for laxatives. This proactive approach is further supported by the increasing prevalence of lifestyle-related diseases, which has heightened awareness of the need for regular bowel movements as part of a healthy lifestyle.

Market Trends

Shift Towards Natural and Herbal Laxatives

The India laxatives market is experiencing a significant shift towards natural and herbal alternatives. Consumers are increasingly seeking products made from traditional ingredients like psyllium husk, senna, and aloe vera, perceiving them as safer and more holistic remedies for digestive issues. This trend aligns with the growing popularity of Ayurveda and traditional Indian medicine. For instance, a substantial portion of the population now prefers Ayurvedic treatments for common ailments, including digestive issues. Many respondents believe natural laxatives offer additional health benefits beyond constipation relief, such as detoxification and improved gut health. Furthermore, sales of herbal laxatives have grown significantly in urban areas, particularly among younger consumers. The study noted that consumers are willing to pay a premium for products that emphasize natural ingredients and traditional formulations. Companies are responding to this trend by launching new product lines that highlight their natural and organic credentials. Marketing strategies often focus on the holistic benefits of these products, appealing to health-conscious consumers interested in overall wellness and preventive care.

Increased Adoption of Convenient and User-Friendly Formats

The India laxatives market is witnessing a notable trend towards more convenient and user-friendly product formats. Traditional powder and tablet forms are being supplemented by innovative options such as capsules, gummies, and ready-to-drink fiber supplements. These new formats are designed to enhance the consumer experience by offering ease of use, better taste, and faster action. The urban consumers, particularly those with busy lifestyles, strongly prefer laxative products that can be easily incorporated into their daily routines. The convenience and palatability are key factors influencing purchase decisions in this category. Additionally, a significant increase in online searches and purchases of laxatives in novel formats. The products marketed as premium or specialty items, often featuring innovative delivery methods, are gaining popularity among younger consumers. The trend is also being driven by increased competition in the market, with companies focusing on product differentiation and innovation. Many manufacturers are investing in research and development to create unique formulations and delivery systems that cater to evolving consumer preferences.

Market Restraints and Challenges

Side Effects and Dependency Concerns

One of the primary restraints in the India laxatives market is the growing concern over the potential side effects and dependency associated with long-term use of laxatives. Frequent use of certain types of laxatives, particularly stimulant laxatives, can lead to issues such as electrolyte imbalances, dehydration, and a weakened bowel function. These risks are particularly concerning for consumers who may rely on laxatives as a regular solution for constipation, leading to a cycle of dependency. For instance, a significant portion of regular laxative users reported experiencing side effects such as abdominal cramps and diarrhea. Additionally, many consumers were unaware of the potential risks associated with long-term laxative use. As awareness about these risks increases, both consumers and healthcare professionals are becoming more cautious about the overuse of laxatives, which can negatively impact market growth. Moreover, there is a rising demand for safer alternatives, such as natural and herbal products, which, while beneficial for the overall market, may limit the growth of traditional laxative products that are perceived as more risky. This shift towards cautious consumption, driven by safety concerns, poses a challenge for manufacturers who need to balance efficacy with safety in their product offerings.

Lack of Awareness and Access in Rural Areas

Despite the overall growth in the India laxatives market, there remains a significant challenge in reaching rural and remote areas where awareness of gastrointestinal health issues and access to laxative products are limited. In many rural regions, digestive health is not given the same level of attention as in urban areas, and traditional remedies are often preferred over modern laxatives. For instance, the disparity in healthcare access between urban and rural areas, with rural populations having significantly lower access to over-the-counter medications, including laxatives. The awareness of gastrointestinal health issues was considerably lower in rural areas compared to urban centers. This lack of awareness, coupled with limited healthcare infrastructure, hampers the penetration of laxative products in these areas. Additionally, the distribution networks in rural India are often underdeveloped, making it difficult for pharmaceutical companies to effectively market and distribute their products. As a result, the market is highly concentrated in urban and semi-urban areas, limiting the potential for growth in rural regions. Overcoming this challenge requires significant investment in education and awareness campaigns, as well as the development of more robust distribution channels, which can be a daunting task for companies operating in this space.

Market Segmentation Analysis

By Drug type

Hyperosmotic laxatives are widely used in India for occasional constipation and rapid relief. For instance, these laxatives are commonly prescribed in both urban and rural healthcare settings due to their effectiveness. Bulk-forming laxatives have gained popularity, especially among the elderly population, as they are considered safer for long-term use. The healthcare providers increasingly recommend bulk-forming laxatives for chronic constipation management. Stool softeners, while having a smaller market share, are frequently used in postoperative care. For example, stool softeners are routinely prescribed to patients recovering from surgeries. Lubricant laxatives, though limited in market presence, still find use in acute care settings. The ‘Others’ category, including stimulant laxatives, has seen a decline in market share due to dependency concerns, as highlighted by a national health survey.

By Indications

Chronic constipation dominates the laxatives market in India, with its prevalence increasing due to urbanization and sedentary lifestyles. For instance, chronic constipation affects a significant portion of the urban population, particularly among office workers and the elderly. The Irritable Bowel Syndrome (IBS) segment is growing steadily, with more people being diagnosed and seeking treatment. IBS-related constipation is becoming more common, especially among young adults. The demand for IBS-specific laxatives, such as bulk-forming and hyperosmotic types, is rising in response to this trend. The “Others” segment, including constipation related to opioid use and other gastrointestinal disorders, is expanding but remains smaller. For example, an increase in opioid-induced constipation cases, contributing to the growth of this segment.

Segments

Based on Drug Type

Hyperosmotic Laxatives
Bulk-Forming Laxatives
Stool Softeners
Lubricants
Others

Based on Indication

Chronic Constipation
Irritable Bowel Syndrome (IBS)
Others

Based on End User

Hospitals & Clinics
Research Institutes
Others

Based on Route of Administration

Oral
Rectal

Based on Region

North
South
East
West

Regional Analysis

North India (35%):

North India holds the largest market share in the India laxatives market, accounting for approximately 35% of the total market. This region’s dominance can be attributed to its well-established healthcare infrastructure, high levels of urbanization, and greater consumer awareness regarding digestive health. For instance, urban areas in North India had the highest prevalence of functional constipation among all regions. Major metropolitan areas such as Delhi, Chandigarh, and Lucknow are key markets within this region, where the demand for both prescription and over-the-counter laxatives is robust. The households in North India spend more on healthcare, including digestive health products, compared to other regions. Additionally, the increasing prevalence of lifestyle-related disorders, particularly among the urban population, drives the demand for laxatives in North India.

West India (30%):

West India is the second-largest market, holding around 30% of the market share. This region benefits from a strong industrial base, with major cities like Mumbai, Pune, and Ahmedabad serving as hubs for pharmaceutical manufacturing and distribution. A study by the All India Institute of Medical Sciences (AIIMS) revealed that the prevalence of irritable bowel syndrome, a condition often treated with laxatives, was highest in Western India compared to other regions. The high concentration of healthcare facilities, coupled with a well-developed retail pharmacy network, makes laxatives widely accessible to consumers in both urban and semi-urban areas. The Annual Health Survey conducted by the Ministry of Health and Family Welfare showed that West Indian states had higher rates of health-seeking behavior for gastrointestinal issues. Moreover, the growing trend of self-medication, supported by easy access to OTC products, contributes significantly to the market’s expansion in West India.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Reddy’s Laboratories Ltd.
Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Sanofi
GSK plc
Novartis AG
AstraZeneca
Pfizer Inc.

Competitive Analysis

The India laxatives market is highly competitive, with key players such as Dr. Reddy’s Laboratories Ltd., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sanofi, GSK plc, Novartis AG, AstraZeneca, and Pfizer Inc. dominating the landscape. These companies leverage their extensive research and development capabilities to innovate and expand their product portfolios, offering a wide range of laxatives, from synthetic to natural and herbal formulations. Their strong distribution networks and established brand recognition give them a competitive edge, allowing them to reach a broad consumer base across urban and rural areas. Additionally, these companies are focusing on strategic collaborations, mergers, and acquisitions to enhance their market presence and drive growth. The competition is further intensified by the increasing demand for safer and more effective laxative products, compelling these players to continually improve their offerings and adapt to changing consumer preferences.

Recent Developments

In February 2023, Reddy’s announced an agreement to acquire the U.S. generic prescription product portfolio of Mayne Pharma Group Limited, which includes some gastrointestinal products. While not specific to laxatives in India, this acquisition could potentially expand their product offerings in related areas.

In October 2023, Sanofi and Teva announced a collaboration to co-develop and co-commercialize TEV’574, a novel treatment for inflammatory bowel disease, including ulcerative colitis and Crohn’s disease. Though not directly a laxative, this development could impact related gastrointestinal treatments in India.

In January 2024, GSK reported strong performance in their consumer healthcare business, which includes over-the-counter products like laxatives. While not specific to India or laxatives, this indicates continued focus on their consumer health portfolio.

In February 2024, AstraZeneca reported strong financial performance and scientific progress, including investments in areas of science that could potentially impact gastrointestinal treatments in the future.

In October 2023, Pfizer reported on their product developments, including progress in various therapeutic areas. While not specific to laxatives in India, their continued focus on research and development could lead to new treatments in related areas.

Market Concentration and Characteristics

The India laxatives market is moderately concentrated, with a mix of both global pharmaceutical giants and local players dominating the landscape. Companies like Dr. Reddy’s Laboratories Ltd., Sanofi, and GSK plc hold significant market shares due to their extensive product portfolios, strong brand presence, and widespread distribution networks. The market is characterized by intense competition, with a focus on innovation, particularly in natural and herbal laxatives, to meet the growing consumer demand for safer and more effective solutions. Additionally, the market is influenced by the rising prevalence of gastrointestinal disorders and the increasing trend towards self-medication, which drives the demand for over-the-counter products. Despite the competition, the market offers substantial growth opportunities, particularly in underserved rural areas and through the development of new, consumer-friendly product formulations.

Report Coverage

The research report offers an in-depth analysis based on Drug Type, Indication, End User, Route of Administration and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The trend towards natural and herbal laxatives is expected to grow as consumers seek safer and more holistic options. Companies will likely expand their product lines to include more plant-based and organic formulations.

Increased healthcare spending in India will drive market growth by enhancing access to advanced laxative treatments. Investments in healthcare infrastructure will improve availability and distribution.

The aging population will significantly boost demand for laxatives, as elderly individuals are more prone to constipation and related issues. This demographic shift will lead to higher consumption of both prescription and OTC laxatives.

Efforts to improve healthcare access in rural areas will open new market opportunities. Companies are likely to focus on developing distribution networks to reach underserved populations.

Innovations in drug delivery systems and formulations will enhance the efficacy and safety of laxatives. Advanced technologies will enable the development of more user-friendly and effective products.

Evolving regulatory standards will impact market dynamics, with increased scrutiny on product safety and efficacy. Companies will need to adapt to new regulations to ensure compliance and maintain market access.

The rise of e-commerce platforms will facilitate easier access to a wide range of laxative products. Online sales channels will become increasingly important for reaching consumers across different regions.

An increasing emphasis on preventive healthcare will drive demand for laxatives as part of broader wellness strategies. Consumers will seek products that promote digestive health and overall well-being.

The market will continue to be highly competitive, with both multinational and local players vying for market share. Competitive strategies will include product differentiation, strategic partnerships, and marketing innovations.

Enhanced consumer education about digestive health will boost market growth. Awareness campaigns and health initiatives will drive informed purchasing decisions and increase the adoption of laxative products.

CHAPTER NO. 1 : INTRODUCTION 13

1.1.1. Report Description 13

Purpose of the Report 13

USP & Key Offerings 13

1.1.2. Key Benefits for Stakeholders 13

1.1.3. Target Audience 14

1.1.4. Report Scope 14

CHAPTER NO. 2 : EXECUTIVE SUMMARY 15

2.1. India Laxatives Market Snapshot 15

2.1.1. India Laxatives Market, 2018 – 2032 (USD Million) 16

CHAPTER NO. 3 : INDIA LAXATIVES MARKET – INDUSTRY ANALYSIS 17

3.1. Introduction 17

3.2. Market Drivers 18

3.2.1. Driving Factor 1 Analysis 18

3.2.2. Driving Factor 2 Analysis 19

3.3. Market Restraints 20

3.3.1. Restraining Factor Analysis 20

3.4. Market Opportunities 21

3.4.1. Market Opportunity Analysis 21

3.5. Porter’s Five Forces Analysis 22

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 23

4.1. Company Market Share Analysis – 2023 23

4.1.1. India Laxatives Market: Company Market Share, by Volume, 2023 23

4.1.2. India Laxatives Market: Company Market Share, by Revenue, 2023 24

4.1.3. India Laxatives Market: Top 6 Company Market Share, by Revenue, 2023 24

4.1.4. India Laxatives Market: Top 3 Company Market Share, by Revenue, 2023 25

4.2. India Laxatives Market Company Revenue Market Share, 2023 26

4.3. Company Assessment Metrics, 2023 27

4.3.1. Stars 27

4.3.2. Emerging Leaders 27

4.3.3. Pervasive Players 27

4.3.4. Participants 27

4.4. Start-ups /SMEs Assessment Metrics, 2023 27

4.4.1. Progressive Companies 27

4.4.2. Responsive Companies 27

4.4.3. Dynamic Companies 27

4.4.4. Starting Blocks 27

4.5. Strategic Developments 28

4.5.1. Acquisitions & Mergers 28

New Product Launch 28

India Expansion 28

4.6. Key Players Product Matrix 29

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 30

5.1. PESTEL 30

5.1.1. Political Factors 30

5.1.2. Economic Factors 30

5.1.3. Social Factors 30

5.1.4. Technological Factors 30

5.1.5. Environmental Factors 30

5.1.6. Legal Factors 30

5.2. Adjacent Market Analysis 30

CHAPTER NO. 6 : INDIA LAXATIVES MARKET – BY DRUG TYPE SEGMENT ANALYSIS 31

6.1. India Laxatives Market Overview, by Drug Type Segment 31

6.1.1. India Laxatives Market Revenue Share, By Drug Type, 2023 & 2032 32

6.1.2. India Laxatives Market Attractiveness Analysis, By Drug Type 33

6.1.3. Incremental Revenue Growth Opportunity, by Drug Type, 2024 – 2032 33

6.1.4. India Laxatives Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 34

6.2. Hyperosmotic 35

6.3. Bulk-Forming 36

6.4. Stool Softeners 37

6.5. Lubricants 38

6.6. Others 39

CHAPTER NO. 7 : INDIA LAXATIVES MARKET – BY INDICATION SEGMENT ANALYSIS 40

7.1. India Laxatives Market Overview, by Indication Segment 40

7.1.1. India Laxatives Market Revenue Share, By Indication, 2023 & 2032 41

7.1.2. India Laxatives Market Attractiveness Analysis, By Indication 42

7.1.3. Incremental Revenue Growth Opportunity, by Indication, 2024 – 2032 42

7.1.4. India Laxatives Market Revenue, By Indication, 2018, 2023, 2027 & 2032 43

7.2. Chronic Constipation 44

7.3. Irritable Bowel Syndrome 45

7.4. Others 46

CHAPTER NO. 8 : INDIA LAXATIVES MARKET – BY END-USER SEGMENT ANALYSIS 47

8.1. India Laxatives Market Overview, by End-user Segment 47

8.1.1. India Laxatives Market Revenue Share, By End-user, 2023 & 2032 48

8.1.2. India Laxatives Market Attractiveness Analysis, By End-user 49

8.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 49

8.1.4. India Laxatives Market Revenue, By End-user, 2018, 2023, 2027 & 2032 50

8.2. Hospitals & Clinics 51

8.3. Research Institutes 52

8.4. Others 53

CHAPTER NO. 9 : INDIA LAXATIVES MARKET – BY ROUTE OF ADMINISTRATION SEGMENT ANALYSIS 54

9.1. India Laxatives Market Overview, by Route of Administration Segment 54

9.1.1. India Laxatives Market Revenue Share, By Route of Administration, 2023 & 2032 55

9.1.2. India Laxatives Market Attractiveness Analysis, By Route of Administration 56

9.1.3. Incremental Revenue Growth Opportunity, by Route of Administration, 2024 – 2032 56

9.1.4. India Laxatives Market Revenue, By Route of Administration, 2018, 2023, 2027 & 2032 57

9.2. Oral 58

9.3. Rectal 59

CHAPTER NO. 10 : COMPANY PROFILES 60

10.1. Reddy’s Laboratories Ltd. 60

10.1.1. Company Overview 60

10.1.2. Product Portfolio 60

10.1.3. Swot Analysis 60

10.1.4. Business Strategy 61

10.1.5. Financial Overview 61

10.2. Hoffmann-La Roche Ltd. 62

10.3. Teva Pharmaceutical Industries Ltd. 62

10.4. Sanofi 62

10.5. GSK plc 62

10.6. Novartis AG 62

10.7. AstraZeneca 62

10.8. Pfizer Inc. 62

CHAPTER NO. 11 : RESEARCH METHODOLOGY 63

11.1. Research Methodology 63

11.1.1. Phase I – Secondary Research 64

11.1.2. Phase II – Data Modeling 64

Company Share Analysis Model 65

Revenue Based Modeling 65

11.1.3. Phase III – Primary Research 66

11.1.4. Research Limitations 67

Assumptions 67

List of Figures

FIG NO. 1. India Laxatives Market Revenue, 2018 – 2032 (USD Million) 17

FIG NO. 2. Porter’s Five Forces Analysis for India Laxatives Market 23

FIG NO. 3. Company Share Analysis, 2023 24

FIG NO. 4. Company Share Analysis, 2023 25

FIG NO. 5. Company Share Analysis, 2023 25

FIG NO. 6. Company Share Analysis, 2023 26

FIG NO. 7. India Laxatives Market – Company Revenue Market Share, 2023 27

FIG NO. 8. India Laxatives Market Revenue Share, By Drug Type, 2023 & 2032 33

FIG NO. 9. Market Attractiveness Analysis, By Drug Type 34

FIG NO. 10. Incremental Revenue Growth Opportunity by Drug Type, 2024 – 2032 34

FIG NO. 11. India Laxatives Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 35

FIG NO. 12. India Laxatives Market for Hyperosmotic, Revenue (USD Million) 2018 – 2032 36

FIG NO. 13. India Laxatives Market for Bulk-Forming, Revenue (USD Million) 2018 – 2032 37

FIG NO. 14. India Laxatives Market for Stool Softeners, Revenue (USD Million) 2018 – 2032 38

FIG NO. 15. India Laxatives Market for Lubricants, Revenue (USD Million) 2018 – 2032 39

FIG NO. 16. India Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 40

FIG NO. 17. India Laxatives Market Revenue Share, By Indication, 2023 & 2032 42

FIG NO. 18. Market Attractiveness Analysis, By Indication 43

FIG NO. 19. Incremental Revenue Growth Opportunity by Indication, 2024 – 2032 43

FIG NO. 20. India Laxatives Market Revenue, By Indication, 2018, 2023, 2027 & 2032 44

FIG NO. 21. India Laxatives Market for Chronic Constipation, Revenue (USD Million) 2018 – 2032 45

FIG NO. 22. India Laxatives Market for Irritable Bowel Syndrome, Revenue (USD Million) 2018 – 2032 46

FIG NO. 23. India Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 47

FIG NO. 24. India Laxatives Market Revenue Share, By End-user, 2023 & 2032 49

FIG NO. 25. Market Attractiveness Analysis, By End-user 50

FIG NO. 26. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 50

FIG NO. 27. India Laxatives Market Revenue, By End-user, 2018, 2023, 2027 & 2032 51

FIG NO. 28. India Laxatives Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 52

FIG NO. 29. India Laxatives Market for Research Institutes, Revenue (USD Million) 2018 – 2032 53

FIG NO. 30. India Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 54

FIG NO. 31. India Laxatives Market Revenue Share, By Route of Administration, 2023 & 2032 56

FIG NO. 32. Market Attractiveness Analysis, By Route of Administration 57

FIG NO. 33. Incremental Revenue Growth Opportunity by Route of Administration, 2024 – 2032 57

FIG NO. 34. India Laxatives Market Revenue, By Route of Administration, 2018, 2023, 2027 & 2032 58

FIG NO. 35. India Laxatives Market for Oral, Revenue (USD Million) 2018 – 2032 59

FIG NO. 36. India Laxatives Market for Rectal, Revenue (USD Million) 2018 – 2032 60

FIG NO. 37. Research Methodology – Detailed View 64

FIG NO. 38. Research Methodology 65

List of Tables

TABLE NO. 1. : India Laxatives Market: Snapshot 16

TABLE NO. 2. : Drivers for the India Laxatives Market: Impact Analysis 19

TABLE NO. 3. : Restraints for the India Laxatives Market: Impact Analysis 21

Frequently Asked Questions:

What is the projected growth rate of the India laxatives market?

The India laxatives market is projected to grow from USD 373.83 million in 2023 to USD 682.72 million by 2032, with a compound annual growth rate (CAGR) of 6.81% from 2024 to 2032.

What factors are driving the growth of the laxatives market in India?

Growth is driven by increasing awareness of gastrointestinal health, a rising geriatric population, and the prevalence of lifestyle-related disorders that contribute to constipation and other digestive issues.

Which regions in India show the highest demand
for laxatives?

The highest demand is concentrated in metropolitan cities such as Mumbai, Delhi, and Bangalore, with the northern and western regions of India leading due to better healthcare infrastructure and consumer spending.

Who are the key players in the India laxatives
market?

Major players include Abbott Laboratories, GlaxoSmithKline Plc, Cipla Ltd., Sanofi S.A., and Bayer AG, all of whom are expanding their product portfolios and market presence through strategic initiatives.

Purchase Options

Single User

$1699

Multi User

$2699

Enterprise

$3699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –